» Articles » PMID: 27580304

Cyclin-dependent Kinase Inhibitor Flavopiridol Promotes Remyelination in a Cuprizone Induced Demyelination Model

Overview
Journal Cell Cycle
Specialty Cell Biology
Date 2016 Sep 1
PMID 27580304
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

The cuprizone (CPZ) model has been widely used for the studies of de-and remyelination. The CPZ-exposed mice show oligodendrocyte precursor cells (OPCs) increase and mature oligodendrocytes decrease, suggesting an imbalance between proliferation and differentiation of OPCs. In the first experiment of this study, we examined the expression of cell cycle related genes in brains of mice following CPZ administration for 5 weeks by means of microarray assay. In addition, we performed a double labeling of BrdU and Ki-67 to calculate cell cycle exit index in the mice. Our results showed that CPZ administration up-regulated the expression of 16 cell cycle related genes, but down-regulated the expression of only one in the prefrontal cortex (PFC) of mice compared to control group. The treatment inhibited potential precursor cells exit from cell cycle. In the second experiment, we evaluated effects of a CDK inhibitor flavopiridol (FLA) on CPZ-induced neuropathological changes and spatial working memory impairment in mice.FLA treatment for one week effectively attenuated the CPZ-induced increases in NG2 positive cells, microglia and astrocytes, alleviated the concurrent mature oligodendrocyte loss and myelin breakdown, and improved spatial working memory deficit in the CPZ-exposed mice. These results suggest that CPZ-induced neuropathological changes involve in dysregulation of cell cycle related genes. The therapeutic effects of FLA on CPZ-exposed mice may be related to its ability of cell cycle inhibition.

Citing Articles

Anti-Inflammatory Effects of Miyako in a Mouse Model of Amyotrophic Lateral Sclerosis and Lipopolysaccharide-Stimulated BV-2 Microglia.

Tsuruta K, Shidara T, Miyagishi H, Nango H, Nakatani Y, Suzuki N Int J Mol Sci. 2023; 24(18).

PMID: 37762010 PMC: 10530530. DOI: 10.3390/ijms241813698.


Remyelination in Multiple Sclerosis: Findings in the Cuprizone Model.

Leo H, Kipp M Int J Mol Sci. 2022; 23(24).

PMID: 36555733 PMC: 9783537. DOI: 10.3390/ijms232416093.


Immunotherapeutic Targeting of NG2/CSPG4 in Solid Organ Cancers.

Zhang H, Wu Z, Hu D, Yan M, Sun J, Lai J Vaccines (Basel). 2022; 10(7).

PMID: 35891187 PMC: 9321363. DOI: 10.3390/vaccines10071023.


Low-field magnetic stimulation improved cuprizone-induced depression-like symptoms and demyelination in female mice.

Mooshekhian A, Sandini T, Wei Z, van Bruggen R, Li H, Li X Exp Ther Med. 2022; 23(3):210.

PMID: 35126713 PMC: 8796645. DOI: 10.3892/etm.2022.11133.


HDAC1 dysregulation induces aberrant cell cycle and DNA damage in progress of TDP-43 proteinopathies.

Wu C, Jin L, Wang I, Wei W, Ho P, Liu Y EMBO Mol Med. 2020; 12(6):e10622.

PMID: 32449313 PMC: 7278561. DOI: 10.15252/emmm.201910622.

References
1.
Weiss R, Matsuoka S, Elledge S, Leder P . Hus1 acts upstream of chk1 in a mammalian DNA damage response pathway. Curr Biol. 2002; 12(1):73-7. DOI: 10.1016/s0960-9822(01)00626-1. View

2.
Bansal R, Pfeiffer S . FGF-2 converts mature oligodendrocytes to a novel phenotype. J Neurosci Res. 1998; 50(2):215-28. DOI: 10.1002/(SICI)1097-4547(19971015)50:2<215::AID-JNR10>3.0.CO;2-7. View

3.
Keirstead H, Blakemore W . The role of oligodendrocytes and oligodendrocyte progenitors in CNS remyelination. Adv Exp Med Biol. 2000; 468:183-97. DOI: 10.1007/978-1-4615-4685-6_15. View

4.
Belachew S, Aguirre A, Wang H, Vautier F, Yuan X, Anderson S . Cyclin-dependent kinase-2 controls oligodendrocyte progenitor cell cycle progression and is downregulated in adult oligodendrocyte progenitors. J Neurosci. 2002; 22(19):8553-62. PMC: 6757806. View

5.
Patil M, Pabla N, Dong Z . Checkpoint kinase 1 in DNA damage response and cell cycle regulation. Cell Mol Life Sci. 2013; 70(21):4009-21. PMC: 3731415. DOI: 10.1007/s00018-013-1307-3. View